Septanazal (xylometazoline, dexpanthenol) nasal spray 1 mg/50 mg/ml. 10 ml. vial

Description

Septanazal (xylometazoline, dexpanthenol) nasal spray 1 mg/50 mg/ml. 10 ml. vial

Composition

active substances: xylometazoline hydrochloride, dexpanthenol;

1 ml of solution contains 1 mg of xylometazoline hydrochloride and 50 mg of dexpanthenol;

one spray of 0.1 ml of solution contains 0.1 mg of xylometazoline hydrochloride and 5.0 mg of dexpanthenol;

excipients: potassium dihydrogen phosphate, disodium hydrogen phosphate dodecahydrate, purified water.

Medicinal form

Nasal spray, solution.

Main physical and chemical properties: transparent colorless liquid.

Pharmacotherapeutic group

Anti-edematous and other rhinological drugs for local use. Sympathomimetics, combinations, with the exception of corticosteroids.
ATX code R01A B06.

Pharmacological properties

Combined rhinological drug Septanazal, which belongs to antimicrobial and antiseptic agents for local use.
Consists of a combination of two active ingredients – dexpanthenol (provitamin B5) and xylometazoline.
Once in the skin cells, it quickly turns into pantothenic acid, which is a component of coenzyme, playing an important role in the metabolism of each cell. Pantothenic acid is therefore essential for the protection, formation and healing of damaged skin and mucous membranes.
Xylometazoline produces a vasoconstrictor effect, as a result of which the swelling of the nasal mucosa is eliminated.

Indications

Septanazal is intended for the treatment of various lesions of the skin and mucous membranes, including:

• nasal congestion during coryza;
• promoting healing of the skin around the nasal passages and disorders of the mucous membrane in the nasal cavity;
• vasomotor rhinitis;
• disturbances in nasal breathing after surgical interventions in the nasal cavity.

Dexpanthenol is a derivative of pantothenic acid. It has the ability to regenerate mucous membranes, normalize cell metabolism, accelerate mitosis and strengthen collagen fibers. It has a regenerating, vitaminizing and anti-inflammatory effect.
The body’s need for pantothenic acid increases with damage to the skin or tissues. This deficiency can be compensated for with the help of topical application of dexpanthenol, since this substance has the property of intensively penetrating all layers of the skin.
Xylometazoline hydrochloride, an imidazole derivative, is an alpha-adrenergic sympathomimetic. It has an effect in 5-10 minutes, the manifestation of which is the relief of nasal breathing and improved excretion of secretions.

Contraindications

Not applicable if the patient has hypersensitivity (allergy) to one of the components of the drug.
It is also contraindicated for use if the patient has dry inflammation of the nasal mucosa, acute coronary diseases, including cardiac asthma, hyperthyroidism, angle-closure glaucoma, a history of surgery with exposure of the meninges.
Also, they are not used with concomitant treatment with MAO inhibitors and within two weeks after the end of therapy with this drug.
In pediatrics, the pediatric form of the drug (from 2 to 6 years old) is used – Septanazal for children.
It is undesirable to use in the case of:

• the use of drugs that increase blood pressure;
• if the patient has increased intraocular pressure;
• the patient suffers from pheochromocytoma;
• the patient suffers from porphyria;
• the patient suffers from prostatic hyperplasia.

Application during pregnancy and lactation

This drug is not used in any trimester of pregnancy.

Method of administration and dosage

Septanazal is intended for topical use.
Apply 1 spray of the drug into each nostril, but no more than 3 times a day, depending on the patient’s individual response to this drug.
When injecting the drug, inhale deeply through the nose.
Do not use the drug for more than 7 days, unless otherwise prescribed by your doctor.
A repeated course can be performed no earlier than after a break of several days and after prior consultation with the attending physician.
In chronic rhinitis, it is permissible to use it only under the supervision of a doctor, because of the danger of atrophy of the nasal mucosa.

Overdose

Decongestant sympathomimetics can, with prolonged use or with an overdose, lead to reactive hyperemia of the nasal mucosa.
Exceeding the recommended treatment time can cause chronic swelling of the nasal mucosa and atrophy of the nasal cavity.
Overdose can lead to effects on the central nervous system, causing depression, which can cause:

• cramping;
• bradycardia;
• apnea;
• arterial hypertension;
• arterial hypotension;
• anxiety;
• excitation;
• hallucinations;
• convulsions.

Additional symptoms are also possible, such as miosis, sweating, nausea, cyanosis, tachycardia, cardiac arrest, pulmonary edema, respiratory depression, impaired consciousness.
In case of overdose, the drug should be discontinued. It is recommended to carry out the treatment of symptoms, you should also rinse the stomach, take enterosorbents.

Side effects

Side effects may occur in the form of:

• disorders of the nervous system – excitement, insomnia, drowsiness, headaches;
• from the CCC – tachycardia, increased blood pressure, arrhythmia;
• seizures, allergic reactions in the form of angioedema, rash, itching;
• discomfort from the nasal mucosa, dryness in the nose, nosebleeds, burning sensations, sneezing.